Detail akcie ASP Isotopes Rg online

Business Summary: ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, ASP Isotopes Inc revenues increased from $3M to $7.2M. Net loss applicable to common stockholders increased from $25.9M to $96.4M. Revenues reflect Specialist isotopes and related services segment increase of 21% to $3.6M. Higher net loss reflects Change in fair value of convertible note increase from $5.2M to $64.5M (expense), General and administrative - Balancing v increase of 68% to $20M (expense).